Albert Rubben

Aachen, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Brief Communication: Treatment Outcomes for Advanced Melanoma of Unknown Primary Compared With Melanoma With Known Primary.

Brief Communication: Treatment Outcomes for Advanced Melanoma of Unknown Primary Compared With Melanoma With Known Primary.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: November 14, 2023

A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score.

A distinct four-value blood signature of pyrexia under combination therapy of malignant melanoma with dabrafenib and trametinib evidenced by an algorithm-defined pyrexia score.

Journal: PloS one
Published: April 18, 2022

Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.

Germline intergenic duplications at Xq26.1 underlie Bazex-Dupré-Christol basal cell carcinoma susceptibility syndrome.

Journal: The British journal of dermatology
Published: March 01, 2022

Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.

Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.

Journal: Journal of personalized medicine
Published: November 28, 2021

Cutaneous Malignancies in Tattoos, a Case Series of Six Patients.

Cutaneous Malignancies in Tattoos, a Case Series of Six Patients.

Journal: Current oncology (Toronto, Ont.)
Published: September 21, 2021

Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients.

Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients.

Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 21, 2020

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.

Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients.

Journal: Journal for immunotherapy of cancer
Published: September 27, 2020

Cutaneous Vasculitis in a Patient With COVID-19.

Cutaneous Vasculitis in a Patient With COVID-19.

Journal: Open forum infectious diseases
Published: August 04, 2020

Side effects of novel cancer immunotherapies

Side effects of novel cancer immunotherapies

Journal: Der nephrologe
Published: May 01, 2020

Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer.

Correlative Monitoring of Immune Activation and Tissue Damage in Malignant Melanoma-An Algorithm for Identification of Tolerance Breakage During Immune Checkpoint Inhibitor Therapy of Cancer.

Journal: International journal of molecular sciences
Published: January 20, 2020

Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype.

Mutation analysis of multiple pilomatricomas in a patient with myotonic dystrophy type 1 suggests a DM1-associated hypermutation phenotype.

Journal: PloS one
Published: November 19, 2019

Herpes simplex virus type-I and pyogenic granuloma: a vascular endothelial growth factor-mediated association?

Herpes simplex virus type-I and pyogenic granuloma: a vascular endothelial growth factor-mediated association?

Journal: Case reports in dermatology
Published: September 11, 2013
Showing 1-12 of 12

Last Updated: 09/26/2026